NCT02440464 2023-01-04Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)National Heart, Lung, and Blood Institute (NHLBI)Phase 2 Completed57 enrolled 22 charts